+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma



Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma



Zhonghua Yu Fang Yi Xue Za Zhi 45(12): 1093-1098



The purpose of this study was to discuss the relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma (HCC) in Chinese population. In this case-control study, 1300 cases of HBV positive patients were recruited in case group and another 1344 cases of persistent chronic HBV carriers were selected as control. 5 ml of blood sample was collected from each subject, from which the DNA was extracted; and rs10877887 and rs13293512 in promoter region let-7 were selected as the study sites. The polymorphism was detected by TaqMan allelic discrimination assay and the OR value (95%CI) was evaluated by Logistic Regression Method to analyze the relationship between susceptibility to HCC and different genotypes. The frequencies of genotype TT, CT and CC in site rs10877887 were 43.0% (542/1261), 44.7% (564/1261) and 12.3% (155/1261) respectively in case group; while separately 44.0% (581/1319), 44.4% (585/1319) and 11.6% (153/1319)in control group. The frequencies of genotype TT, CT and CC in site rs13293512 were 32.0% (406/1270), 48.1% (611/1270) and 19.9% (253/1270) respectively in case group; while separately 33.1% (427/1291), 49.4% (638/1291) and 17.5% (226/1291) in control group. The results of multifactor logistic regression analysis showed no statistical significance in the relationship between different genotype TT, mutated genotype C in site rs10877887 and susceptibility to HCC (CC + CT vs TT, adjusted OR = 1.05, 95%CI: 0.90 - 1.23); and either no statistical significance in the relationship between different genotype TT, mutated genotype C in site rs13293512 and susceptibility to HCC (CC + CT vs TT, adjusted OR = 1.06, 95%CI: 0.89 - 1.25). The united-analysis of the two sites showed the frequencies of 0, 1, 2 and 3-4 mutated-genotype C were 13.3% (164/1235), 36.2% (447/1235), 33.0% (408/1235) and 17.5% (216/1235) respectively in case group; and separately 14.2% (181/1269), 37.0% (469/1269), 33.1% (420/1269) and 15.7% (199/1269) in control group. The susceptibility to HCC in 1,2,3-4 mutated-genotype C carriers were 1.05 (0.81 - 1.34), 1.07 (0.83 - 1.38) and 1.22 (0.91 - 1.62) times of the non-mutated genotype subjects; but there was no statistical significance (Wald χ(2) = 1.79, P = 0.181). The polymorphism of study sites rs10877887 and rs13293512 may not be the biomarker of susceptibility to HCC in Chinese.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055465715

Download citation: RISBibTeXText

PMID: 22336344


Related references

Relationship between hepatitis B virus infection, the L-myc and GST M1 genetic polymorphism and susceptibility to hepatocellular carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 36: 121, 1995

The relationship between the KIF1B (rs17401966) single nucleotide polymorphism and the genetic susceptibility to Hepatocellular carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi 49(5): 419-423, 2015

Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi 45(3): 239-243, 2011

Genetic polymorphism of UDP-glucuronosyltransferase 1F and susceptibility to hepatocellular carcinoma. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19(4): 324-328, 2002

Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma. Journal of Surgical Oncology 102(3): 264-270, 2010

Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma. Cellular Immunology 294(1): 21-24, 2015

A p53 genetic polymorphism associated with susceptibility to hepatocellular carcinoma among chronic hepatitis B carriers. Anticancer Research 18(6C): 4976-4977, 1998

Association of p53 codon 72 polymorphism with genetic susceptibility to hepatocellular carcinoma in Chinese population bb. Zhonghua Yixue Yichuanxue Zazhi 22(6): 632-635, 2005

A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 14(3): 196-198, 2006

P53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population. Zhonghua Yi Xue Za Zhi 85(2): 76-79, 2005

Association between MKK4 promoter-1304T/G polymorphism and genetic susceptibility in sporadic nasopharyngeal carcinoma. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 30(4): 287-290, 2016

Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Infection Genetics and Evolution 11(8): 2083-2088, 2011

Relationship between genetic polymorphisms of N-acetyltransferase and susceptibility to hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 11(1): 20-22, 2003

The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis. Asian Pacific Journal of Cancer Prevention 14(10): 5761-5767, 2013

Association between KIF1B rs17401966 genetic polymorphism and hepatocellular carcinoma susceptibility: an updated meta-analysis. Bmc Medical Genetics 20(1): 59, 2019